Skip to main content
SpringerLink
Log in

Katheterablation von Vorhofflimmern

Aktueller Stand

Catheter ablation of atrial fibrillation

Status quo

  • Schwerpunkt
  • Published:
Herzschrittmachertherapie + Elektrophysiologie Aims and scope Submit manuscript

Zusammenfassung

Die Katheterablation bei Vorhofflimmern hat einen festen Platz im Arm der Rhythmuskontrolle. Dieser Beitrag fasst den aktuellen Stand der Katheterablation bei Vorhofflimmern zusammen, bestehend aus den Indikationen, den zur Verfügung stehenden Ablationsenergien, dem prozeduralen Vorgehen sowie dem Endpunkt, dem Follow-up und der Antikoagulation.

Abstract

Catheter ablation of atrial fibrillation (AF) is a standard part of treatment with respect to rhythm control. In this article, the authors provide a review of the state-of-the-art knowledge of AF catheter ablation including current indications, possible energy forms, procedural methods and endpoints as well as follow-up and further anticoagulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, Haeusler KG, Oldgren J, Reinecke H, Roldan-Schilling V, Rowell N, Sinnaeve P, Collins R, Camm AJ, Heidbüchel H, ESC Scientific Document Group. (2018) The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J 39(16):1330–1393. https://doi.org/10.1093/eurheartj/ehy136

    Article  CAS  PubMed  Google Scholar 

  2. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P, Agewall S, Camm J, Baron Esquivias G, Budts W, Carerj S, Casselman F, Coca A, De Caterina R, Deftereos S, Dobrev D, Ferro JM, Filippatos G, Fitzsimons D, Gorenek B, Guenoun M, Hohnloser SH, Kolh P, Lip GY, Manolis A, McMurray J, Ponikowski P, Rosenhek R, Ruschitzka F, Savelieva I, Sharma S, Suwalski P, Tamargo JL, Taylor CJ, Van Gelder IC, Voors AA, Windecker S, Zamorano JL, Zeppenfeld K (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace 18(11):1609–1678

    Article  Google Scholar 

  3. Jaïs P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R, Hocini M, Extramiana F, Sacher F, Bordachar P, Klein G, Weerasooriya R, Clémenty J, Haïssaguerre M (2008) Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 118(24):2498–2505. https://doi.org/10.1161/CIRCULATIONAHA.108.772582

    Article  PubMed  Google Scholar 

  4. Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, Merkely B, Pokushalov E, Sanders P, Proff J, Schunkert H, Christ H, Vogt J, Bänsch D, CASTLE-AF Investigators. (2018) Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 378(5):417–427. https://doi.org/10.1056/NEJMoa1707855

    Article  PubMed  Google Scholar 

  5. Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Nielsen JC, Curtis AB, Wyn Davies D, Day JD, d’Avila A, de Groot NMSN, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T (2017) 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. J Interv Card Electrophysiol 50(1):1–55. https://doi.org/10.1007/s10840-017-0277-z

    Article  PubMed  PubMed Central  Google Scholar 

  6. Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE, Noseworthy PA, Rosenberg YD, Jeffries N, Mitchell LB, Flaker GC, Pokushalov E, Romanov A, Bunch TJ, Noelker G, Ardashev A, Revishvili A, Wilber DJ, Cappato R, Kuck KH, Hindricks G, Davies DW, Kowey PR, Naccarelli GV, Reiffel JA, Piccini JP, Silverstein AP, Al-Khalidi HR, Lee KL, CABANA Investigators. (2019) Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA 321(13):1261–1274. https://doi.org/10.1001/jama.2019.0693

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P, Clémenty J (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339(10):659–666

    Article  Google Scholar 

  8. Kuck KH, Hoffmann BA, Ernst S, Wegscheider K, Treszl A, Metzner A, Eckardt L, Lewalter T, Breithardt G, Willems S, Gap-AF–AFNET 1 Investigators (2016) Impact of complete versus incomplete circumferential lines around the pulmonary veins during catheter ablation of paroxysmal atrial fibrillation: results from the gap-atrial fibrillation-German atrial fibrillation competence network 1 trial. Circ Arrhythm Electrophysiol 9(1):e3337. https://doi.org/10.1161/CIRCEP.115.003337

    Article  PubMed  Google Scholar 

  9. Verma A, Mantovan R, Macle L, De Martino G, Chen J, Morillo CA, Novak P, Calzolari V, Guerra PG, Nair G, Torrecilla EG, Khaykin Y (2010) Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial. Eur Heart J 31(11):1344–1356. https://doi.org/10.1093/eurheartj/ehq041

    Article  PubMed  PubMed Central  Google Scholar 

  10. Koichi I (2019) Effect of extensive ablation on recurrence in patients with persistent atrial fibrillation treated with pulmonary vein isolation. A multicenter, randomized, open-label, non-inferiority study. ESC 2019, Presentation.

    Google Scholar 

  11. Mohanty S, Mohanty P, Trivedi C, Gianni C, Della Rocca DG, Di Biase L, Natale A (2018) Long-term outcome of pulmonary vein isolation with and without focal impulse and rotor modulation mapping. Insights from a meta-analysis. Circulation 11:e5789

    PubMed  Google Scholar 

  12. Santangeli P, Marchlinski FE (2017) Techniques for the provocation, localization, and ablation of non-pulmonary vein triggers for atrial fibrillation. Heart Rhythm 14(7):1087–1096. https://doi.org/10.1016/j.hrthm.2017.02.030

    Article  PubMed  Google Scholar 

  13. Kuck KH, Brugada J, Fürnkranz A, Metzner A, Ouyang F, Chun KR, Elvan A, Arentz T, Bestehorn K, Pocock SJ, Albenque JP, Tondo C, FIRE AND ICE Investigators. (2016) Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med 374(23):2235–2245

    Article  Google Scholar 

  14. Ücer E, Janeczko Y, Seegers J, Fredersdorf S, Friemel S, Poschenrieder F, Maier LS, Jungbauer CG (2018) A Randomized Trial to compare the acute reconnection after pulmonary vein ISolation with Laser-BalloON versus radiofrequency Ablation: RATISBONA trial. J Cardiovasc Electrophysiol 29(5):733–739. https://doi.org/10.1111/jce.13465 (Epub 2018 Mar 8)

    Article  PubMed  Google Scholar 

  15. Dukkipati SR, Cuoco F, Kutinsky I, Aryana A, Bahnson TD, Lakkireddy D, Woollett I, Issa ZF, Natale A, Reddy VY, HeartLight Study Investigators (2015) Pulmonary Vein Isolation Using the Visually Guided Laser Balloon: A Prospective, Multicenter, and Randomized Comparison to Standard Radiofrequency Ablation. J Am Coll Cardiol 66(12):1350–1360. https://doi.org/10.1016/j.jacc.2015.07.036

    Article  PubMed  Google Scholar 

  16. Bordignon S, Chun KR, Gunawardene M, Fuernkranz A, Urban V, Schulte-Hahn B, Nowak B, Schmidt B (2013) Comparison of balloon catheter ablation technologies for pulmonary vein isolation: the laser versus cryo study. J Cardiovasc Electrophysiol 24(9):987–994. https://doi.org/10.1111/jce.12192

    Article  PubMed  Google Scholar 

  17. Bourier F, Duchateau J, Vlachos K, Lam A, Martin CA, Takigawa M, Kitamura T, Frontera A, Cheniti G, Pambrun T, Klotz N, Denis A, Derval N, Cochet H, Sacher F, Hocini M, Haïssaguerre M, Jais P (2018) High-power short-duration versus standard radiofrequency ablation: Insights on lesion metrics. J Cardiovasc Electrophysiol 29(11):1570–1575. https://doi.org/10.1111/jce.13724

    Article  PubMed  Google Scholar 

  18. Beinart R, Abbara S, Blum A, Ferencik M, Heist K, Ruskin J, Mansour M (2011) Left atrial wall thickness variability measured by CT scans in patients undergoing pulmonary vein isolation. J Cardiovasc Electrophysiol 22(11):1232–1236. https://doi.org/10.1111/j.1540-8167.2011.02100.x

    Article  PubMed  Google Scholar 

  19. Reddy VY, Grimaldi M, De Potter T, Vijgen JM, Bulava A, Duytschaever MF, Martinek M, Natale A, Knecht S, Neuzil P, Pürerfellner H (2019) Pulmonary vein isolation with very high power, short duration, temperature-controlled lesions: the QDOT-FAST trial. JACC Clin Electrophysiol 5(7):778–786. https://doi.org/10.1016/j.jacep.2019.04.009

    Article  PubMed  Google Scholar 

  20. Bunch TJ, May HT, Bair TL, Crandall BG, Cutler MJ, Mallender C, Weiss JP, Osborn JS, Day JD (2019) Long-term outcomes after low power, slower movement versus high power, faster movement irrigated-tip catheter ablation for atrial fibrillation. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2019.08.001

    Article  PubMed  Google Scholar 

  21. Reddy VY, Dukkipati SR, Neuzil P, Natale A, Albenque JP, Kautzner J, Shah D, Michaud G, Wharton M, Harari D, Mahapatra S, Lambert H, Mansour M (2015) Randomized, controlled trial of the safety and effectiveness of a contact force-sensing irrigated catheter for ablation of paroxysmal atrial fibrillation: results of the TactiCath contact force ablation catheter study for atrial fibrillation (TOCCASTAR) study. Circulation 132(10):907–915. https://doi.org/10.1161/CIRCULATIONAHA.114.014092

    Article  PubMed  Google Scholar 

  22. Reddy VY, Neuzil P, Koruth JS, Petru J, Funosako M, Cochet H, Sediva L, Chovanec M, Dukkipati SR, Jais P (2019) Pulsed field ablation for pulmonary vein isolation in atrial fibrillation. J Am Coll Cardiol 74(3):315–326. https://doi.org/10.1016/j.jacc.2019.04.021

    Article  PubMed  Google Scholar 

  23. Anter E, Tschabrunn CM, Contreras-Valdes FM, Li J, Josephson ME (2015) Pulmonary vein isolation using the Rhythmia mapping system: Verification of intracardiac signals using the Orion mini-basket catheter. Heart Rhythm 12(9):1927–1934. https://doi.org/10.1016/j.hrthm.2015.05.019

    Article  PubMed  Google Scholar 

  24. Papageorgiou N, Providência R, Srinivasan N, Bronis K, Costa FM, Cavaco D, Adragão P, Tousoulis D, Hunter RJ, Schilling RJ, Segal OR, Chow A, Rowland E, Lowe M, Lambiase PD (2017) Adenosine-guided pulmonary vein isolation versus conventional pulmonary vein isolation in patients undergoing atrial fibrillation ablation: An updated meta-analysis. Int J Cardiol 227:151–160. https://doi.org/10.1016/j.ijcard.2016.11.152

    Article  PubMed  Google Scholar 

  25. Blandino A, Biondi-Zoccai G, Battaglia A, Grossi S, Bianchi F, Conte MR, Rametta F, Gaita F (2017) Impact of targeting adenosine-induced transient venous reconnection in patients undergoing pulmonary vein isolation for atrial fibrillation: a meta-analysis of 3524 patients. J Cardiovasc Med 18(7):478–489. https://doi.org/10.2459/JCM.0000000000000408

    Article  CAS  Google Scholar 

  26. Macle L, Khairy P, Weerasooriya R, Novak P, Verma A, Willems S, Arentz T, Deisenhofer I, Veenhuyzen G, Scavée C, Jaïs P, Puererfellner H, Levesque S, Andrade JG, Rivard L, Guerra PG, Dubuc M, Thibault B, Talajic M, Roy D, Nattel S, ADVICE trial investigators (2015) Adenosine-guided pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation: an international, multicentre, randomised superiority trial. Lancet 386(9994):672–679. https://doi.org/10.1016/S0140-6736(15)60026-5

    Article  PubMed  Google Scholar 

  27. Kobori A, Shizuta S, Inoue K, Kaitani K, Morimoto T, Nakazawa Y, Ozawa T, Kurotobi T, Morishima I, Miura F, Watanabe T, Masuda M, Naito M, Fujimoto H, Nishida T, Furukawa Y, Shirayama T, Tanaka M, Okajima K, Yao T, Egami Y, Satomi K, Noda T, Miyamoto K, Haruna T, Kawaji T, Yoshizawa T, Toyota T, Yahata M, Nakai K, Sugiyama H, Higashi Y, Ito M, Horie M, Kusano KF, Shimizu W, Kamakura S, Kimura T, UNDER-ATP Trial Investigators. (2015) Adenosine triphosphate-guided pulmonary vein isolation for atrial fibrillation: the UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate (UNDER-ATP) trial. Eur Heart J 36(46):3276–3287. https://doi.org/10.1093/eurheartj/ehv457

    Article  CAS  PubMed  Google Scholar 

  28. Halbfass P, Müller P, Nentwich K, Krug J, Roos M, Hamm K, Barth S, Szöllösi A, Mügge A, Schieffer B, Deneke T (2017) Incidence of asymptomatic oesophageal lesions after atrial fibrillation ablation using an oesophageal temperature probe with insulated thermocouples: a comparative controlled study. Europace 19(3):385–391. https://doi.org/10.1093/europace/euw070

    Article  PubMed  Google Scholar 

  29. Linhart M, Nielson A, Andrié RP, Mittmann-Braun EL, Stöckigt F, Kreuz J, Nickenig G, Schrickel JW, Lickfett LM (2014) Fluoroscopy of spontaneous breathing is more sensitive than phrenic nerve stimulation for detection of right phrenic nerve injury during cryoballoon ablation of atrial fibrillation. J Cardiovasc Electrophysiol 25(8):859–865. https://doi.org/10.1111/jce.12431

    Article  PubMed  Google Scholar 

  30. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Natale A, Packer D, Skanes A, Ambrogi F, Biganzoli E (2010) Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 3(1):32–38. https://doi.org/10.1161/CIRCEP.109.859116

    Article  PubMed  Google Scholar 

  31. Willems S, Khairy P, Andrade JG, Hoffmann BA, Levesque S, Verma A, Weerasooriya R, Novak P, Arentz T, Deisenhofer I, Rostock T, Steven D, Rivard L, Guerra PG, Dyrda K, Mondesert B, Dubuc M, Thibault B, Talajic M, Roy D, Nattel S, Macle L; ADVICE Trial Investigators (2016) Redefining the Blanking Period After Catheter Ablation for Paroxysmal Atrial Fibrillation: Insights From the ADVICE (Adenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimination) Trial. Circ Arrhythm Electrophysiol 9(e003909):8. https://doi.org/10.1161/CIRCEP.115.003909

    Article  Google Scholar 

  32. Forkmann M, Schwab C, Edler D, Vevecka A, Butz S, Haller B, Brachmann J, Busch S (2019) Characteristics of early recurrences detected by continuous cardiac monitoring influencing the long-term outcome after atrial fibrillation ablation. J Cardiovasc Electrophysiol. https://doi.org/10.1111/jce.14109

    Article  PubMed  Google Scholar 

  33. Piccini JP, Passman R, Turakhia M, Connolly AT, Nabutovsky Y, Varma N (2019) Atrial fibrillation burden, progression, and the risk of death: a case-crossover analysis in patients with cardiac implantable electronic devices. Europace 21(3):404–413. https://doi.org/10.1093/europace/euy222

    Article  PubMed  Google Scholar 

  34. Pokushalov E, Romanov A, Corbucci G, Bairamova S, Losik D, Turov A, Shirokova N, Karaskov A, Mittal S, Steinberg JS (2012) Does atrial fibrillation burden measured by continuous monitoring during the blanking period predict the response to ablation at 12-month follow-up? Heart Rhythm 9(9):1375–1379. https://doi.org/10.1016/j.hrthm.2012.03.047

    Article  PubMed  Google Scholar 

  35. Schrickel JW, Linhart M, Bänsch D, Thomas D, Nickenig G (2016) Rationale and design of the ODIn-AF Trial: randomized evaluation of the prevention of silent cerebral thromboembolism by oral anticoagulation with dabigatran after pulmonary vein isolation for atrial fibrillation. Clin Res Cardiol 105(2):95–105. https://doi.org/10.1007/s00392-015-0933-1

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Peter-Osypka-Herzzentrum München, Internistisches Klinikum München Süd, Am Isarkanal 36, 81379, München, Deutschland

    Clemens Jilek &  Thorsten Lewalter

Authors
  1. Clemens Jilek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thorsten Lewalter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Clemens Jilek.

Ethics declarations

Interessenkonflikt

C. Jilek und T. Lewalter erhielt Vortragshonorare und Kongressunterstützung von Abbott, Bayer, Biotronik, Boston Scientific, Bristol-Myers Squibb, Medtronic und Pfizer sowie Forschungsunterstützung von Biotronik und Boston Scientific, T. Lewalter zusätzlich auch von Cardiofocus jeweils in geringem Umfang.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jilek, C., Lewalter, T. Katheterablation von Vorhofflimmern. Herzschr Elektrophys 30, 343–348 (2019). https://doi.org/10.1007/s00399-019-00655-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00399-019-00655-w

Schlüsselwörter

Keywords

Search

Navigation